Literature DB >> 21034821

Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332.

F Van den Bergh1, S L Eliason, G J Giudice.   

Abstract

Collagen XVII (COL17) is a transmembrane glycoprotein that is expressed on the basal surface of basal epidermal keratinocytes. Previous observations have led to the hypothesis that an interaction between COL17 and laminin 332, an extracellular matrix protein, contributes to the attachment of the basal keratinocyte to the basement membrane. In order to isolate and manipulate COL17 interactions with ECM components, we induced COL17 expression in two cells lines, SK-MEL1 and K562, that exhibit little or no capacity to attach to our test substrates, including laminin 332, types I and IV collagen, and fibronectin. Cells expressing high levels of COL17 preferentially adhered to a laminin 332 matrix, and, to a lesser extent, type IV collagen, while showing little or no binding to type I collagen or fibronectin. A quantitative analysis of cell adhesive forces revealed that, compared with COL17-negative cells, COL17-positive cells required over 7-fold greater force to achieve 50% detachment from a laminin 332 substrate. When a cell preparation (either K562 or SK-MEL1) with heterogeneous COL17 expression levels was allowed to attach to a laminin 332 matrix, the COL17-positive and COL17-negative cells differentially sorted to the bound and unbound cell fractions, respectively. COL17-dependent attachment to laminin 332 could be reduced or abolished by siRNA-mediated knock-down of COL17 expression or by adding to the assay wells specific antibodies against COL17 or laminin 332. These findings provide strong support for the hypothesis that cell surface COL17 can interact with laminin 332 and, together, participate in the adherence of a cell to the extracellular matrix.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034821      PMCID: PMC3057348          DOI: 10.1016/j.matbio.2010.10.005

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  34 in total

1.  A centrifugation cell adhesion assay for high-throughput screening of biomaterial surfaces.

Authors:  Catherine D Reyes; Andrés J García
Journal:  J Biomed Mater Res A       Date:  2003-10-01       Impact factor: 4.396

2.  Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180.

Authors:  G J Giudice; D J Emery; L A Diaz
Journal:  J Invest Dermatol       Date:  1992-09       Impact factor: 8.551

3.  Generalized atrophic benign epidermolysis bullosa.

Authors:  H Hintner; K Wolff
Journal:  Arch Dermatol       Date:  1982-06

4.  Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome.

Authors:  L A Diaz; H Ratrie; W S Saunders; S Futamura; H L Squiquera; G J Anhalt; G J Giudice
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

5.  A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

Authors:  Z Liu; L A Diaz; J L Troy; A F Taylor; D J Emery; J A Fairley; G J Giudice
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

6.  Control of the distribution of hemidesmosome components in cultured keratinocytes: Ca2+ and phorbol esters.

Authors:  Y Kitajima; K Owaribe; Y Nishizawa; H Yaoita
Journal:  J Dermatol       Date:  1992-11       Impact factor: 4.005

7.  Targeted inactivation of murine laminin gamma2-chain gene recapitulates human junctional epidermolysis bullosa.

Authors:  Xianmin Meng; John F Klement; Dominic A Leperi; David E Birk; Takako Sasaki; Rupert Timpl; Jouni Uitto; Leena Pulkkinen
Journal:  J Invest Dermatol       Date:  2003-10       Impact factor: 8.551

8.  Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.

Authors:  R S Labib; G J Anhalt; H P Patel; D F Mutasim; L A Diaz
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

9.  Collagen XVII participates in keratinocyte adhesion to collagen IV, and in p38MAPK-dependent migration and cell signaling.

Authors:  Hongjiang Qiao; Akihiko Shibaki; Heather A Long; Gang Wang; Qiang Li; Wataru Nishie; Riichiro Abe; Masashi Akiyama; Hiroshi Shimizu; James R McMillan
Journal:  J Invest Dermatol       Date:  2009-02-26       Impact factor: 8.551

10.  Keratinocytes from patients lacking collagen XVII display a migratory phenotype.

Authors:  Kaisa Tasanen; Lucy Tunggal; Gretel Chometon; Leena Bruckner-Tuderman; Monique Aumailley
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

View more
  17 in total

1.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

2.  Dynamic interactions of epidermal collagen XVII with the extracellular matrix: laminin 332 as a major binding partner.

Authors:  Wataru Nishie; Dimitra Kiritsi; Alexander Nyström; Silke C Hofmann; Leena Bruckner-Tuderman
Journal:  Am J Pathol       Date:  2011-06-14       Impact factor: 4.307

Review 3.  Intermediate Filaments and the Plasma Membrane.

Authors:  Jonathan C R Jones; Chen Yuan Kam; Robert M Harmon; Alexandra V Woychek; Susan B Hopkinson; Kathleen J Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-01-03       Impact factor: 10.005

4.  Tapping basement membrane motifs: Oral junctional epithelium for surface-mediated soft tissue attachment to prevent failure of percutaneous devices.

Authors:  Nicholas G Fischer; Alexandra C Kobe; Jinhong Dai; Jiahe He; Hongning Wang; John A Pizarek; David A De Jong; Zhou Ye; Shengbin Huang; Conrado Aparicio
Journal:  Acta Biomater       Date:  2021-12-29       Impact factor: 8.947

5.  Keratinocyte-Specific Peptide-Based Surfaces for Hemidesmosome Upregulation and Prevention of Bacterial Colonization.

Authors:  Nicholas G Fischer; Dina G Moussa; Erik P Skoe; David A De Jong; Conrado Aparicio
Journal:  ACS Biomater Sci Eng       Date:  2020-08-10

6.  Targeting of Cell Surface Proteolysis of Collagen XVII Impedes Squamous Cell Carcinoma Progression.

Authors:  Célimène Galiger; Stefanie Löffek; Marc P Stemmler; Jasmin K Kroeger; Venugopal R Mittapalli; Lisa Fauth; Philipp R Esser; Johannes S Kern; Frank Meiss; Silke Laßmann; Leena Bruckner-Tuderman; Claus-Werner Franzke
Journal:  Mol Ther       Date:  2017-09-27       Impact factor: 11.454

7.  Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD.

Authors:  Soundarapandian Vijayakumar; Suparna Dang; M Peter Marinkovich; Zelmira Lazarova; Bradley Yoder; Vicente E Torres; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-26

Review 8.  Molecular architecture and function of the hemidesmosome.

Authors:  Gernot Walko; Maria J Castañón; Gerhard Wiche
Journal:  Cell Tissue Res       Date:  2015-05-29       Impact factor: 5.249

Review 9.  Molecular architecture and function of the hemidesmosome.

Authors:  Gernot Walko; Maria J Castañón; Gerhard Wiche
Journal:  Cell Tissue Res       Date:  2014-12-09       Impact factor: 5.249

10.  Molecular identification of collagen 17a1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in mice.

Authors:  Thomas J Sproule; Jason A Bubier; Fiorella C Grandi; Victor Z Sun; Vivek M Philip; Caroline G McPhee; Elisabeth B Adkins; John P Sundberg; Derry C Roopenian
Journal:  PLoS Genet       Date:  2014-02-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.